By Rory McCann, Director of Marketing & Conference Producer, LSN

RESI JPM San Francisco, January 10-12, 2023 is Life Science Nation (LSN)’s next hybrid event, taking place during J.P. Morgan Healthcare week, taking advantage of the convergence of life science and healthcare leaders to San Francisco. RESI, as a powerful early-stage deal-making vehicle, is the perfect option for fundraising executives seeking connection with investors and licensing partners in 2023. One of the many meaningful methods RESI uses to connect entrepreneurs with potential partners is through investor panels discussing the latest industry trends, with valuable insights as to standing out to and communicating with potential partners.

A recent RESI Boston attendee praised the panels she attended, saying that by simply attending a panel, she was able to learn enough about an investor to touch base and book a meeting onsite that day. Don’t miss out on the countless opportunities RESI San JPM Francisco panels have to fast-track an introduction and lead to meaningful conversations. Check out the panel lineup below and sign up for Digital RESI November (virtual partnering only) with RESI San JPM Francisco and save $1,000 by tomorrow!

Tuesday, January 10, 8:00 – 8:50 AM PST

Angels and Family Offices
How Do Family Offices & Angels View Seed & Series A Rounds?

Angel investors are a mainstay in the earliest financing rounds, and many consider Family Offices as the holy grail of investors. These groups share many similarities, and can work in synergy to help their portfolio companies advance. This panel will cover topics such as:

• What are the similarities and differences between Angels and Family Offices?
• What are the benefits of working with each group?
• How does investing personal money change the way Angels and Family Offices act from the traditional VC?

A startup looks to many different kinds of investors when fundraising, and understanding the fundamental differences between groups can improve the success of their approach. Angels and Family Offices frequently invest early on, and can shape the way a company develops. Panelists will discuss how best to approach them and engage their interest.

---

Tuesday, January 10, 9:00 – 9:50 AM PST

Big Pharma
Strategies for Preclinical & Early Clinical Assets

In recent years, big pharma companies have begun looking outwards for innovative new therapeutics to add to their pipelines. This panel brings together speakers from various big pharma companies to discuss topics such as:

• How big pharma sources assets
• The evaluation and investment process
• Key factors of interest
• How early-stage big pharma is willing to look

These panelists will shed light on the process that big pharma goes through when sourcing early-stage assets and advise startups on how they can best make a case for themselves. Panelists will also explore various trends within the therapeutics marketplace, what assets are of interest to their company, and what they think will be big in the future.

---

Tuesday, January 10, 10:00 – 10:50 AM PST

Pitching Your AI to Investors
Strategies for Standing Out

AI is embedded in the tech of many life science startups, but are they utilizing it to stand out to investors? Hear from life science and tech investors on how early-stage founders can pitch their AI technology effectively. The right connection can start with a strong first impression, so learn how to bring your tech from pitch to partnership.

---

Tuesday, January 10, 11:00 – 11:50 AM PST

Pediatrics
Advancing Treatments for Pediatric Patients

Since 2015, the US regulatory, public/private payor, and clinical research environments have implemented sweeping changes to the policies and requirements governing healthcare innovation targeting the pediatric patient population. Despite these changes, funding for pediatric innovation remains exponentially lower relative to the nature of the commitments being made to adult indications, especially troubling in light of nearly 40% of the world’s population will be under the age of 21, yet less

than 15% of all healthcare investment is targeting pediatric indications. This panel will explore several topics including:

• What are the specific gaps in pediatric patient engagement?
• How and why are current novel treatments under development superior to historic care options?
• What are the challenges that impact the efficiency, effectiveness, and successful commercialization of scientific innovations targeting the pediatric patient population?
• What changes need to be made to incentivize and motivate global healthcare manufacturers to increase their pediatric healthcare R&D budgets respectively?

Panelists will discuss topics relevant to all areas of pediatric care and the importance of addressing an underserved population, and how improvements to pediatric care can save long-term costs for the healthcare industry long after these patients reach adulthood.

---

Tuesday, January 10, 1:00 – 1:50 PM PST

Asia Cross Border
Building Global Partnerships

These days, seeking capital from Asia-headquartered investors, pharmaceuticals, and other strategic partners may seem like nothing new. Many groups continue to expand into geographies outside of Asia to set up new offices, establishing open innovation departments, etc. However, companies based in the USA, Europe, and other parts of the world without any proper connection to Asia still find themselves struggling to engage with the right groups. This panel will discuss the following topics and more:

• How are Asian markets and regulatory hurdles different from those of the USA/Europe?
• What do cross-border investors seek in companies outside of Asia? How are they similar or different to their viewpoint on domestic companies?
• How has COVID positively or negatively impacted the decision making process?
• Aside from the effects of COVID on the industry, will cross-border investment activities continue to increase?
• What are some common mistakes investors see from entrepreneurs, and how can they be avoided?

Panelists will discuss how they have been evaluating opportunities in the midst of the COVID pandemic and what the future holds for cross-border activities in the industry. Panelists will also uncover general topics such as navigating the Asian market and the regulatory challenges associated with market entry, how to approach Asian investors and strategic groups, and more.

---

Tuesday, January 10, 2:00 – 2:50 PM PST

Longevity Investment
Aging Innovation for a Better Future

This panel will feature investors that focus on longevity. Learn about their investment preferences and how they evaluate and manage their relationships with their early-stage portfolio and prospects in this specific market. Hear from active age-tech experts on their predictions for the future of this sector.

---

Tuesday, January 10, 3:00 – 3:50 PM PST

Medtech Strategics
Large Corporations Seeking External Innovation in the MedTech Space

In the medical technology sector, major corporations are increasingly looking to external startups and inventors for innovative new technologies. In addition to traditional M&A, these major strategic players are exploring innovative strategies to partner with early stage startups, and our speakers will explore topics such as:

• How do major corporations find new device technologies that are a fit for their pipelines?
• What can an early stage startup do to find the right partner?
• How do partnerships work, and what conditions might a major partner have?
• What kind of technical and commercial validation will be required to secure a partnership?
• The panelists will explore these topics with reference to the technology areas that they are looking at for their future pipelines.
  

  ---

Tuesday, January 10, 4:00 – 4:50 PM PST

Corporate VC
The Changing Landscape & New Opportunities

Corporate venture capital firms are an important source of capital for early-stage companies. Many major pharmaceuticals and large corporations have set up a corporate investment arm to identify early-stage companies. Strategically and financially driven in varying degrees, the implications of working with CVCs are huge, as the resources, network, and guidance provided by the CVC and the associated parent company are incredibly valuable to an entrepreneur who is actively growing their business.

This panel will discuss the following topics and more:

• How are CVCs different from traditional VCs?
• How strategically vs. financially are CVCs driven, and how does this affect their decision-making process?
• How closely does the CVC communicate with the parent company?
• What does working with a CVC entail?

Panelists will discuss each of their investment mandates and how they relate to corporate interests, and how they have been sourcing opportunities during COVID. Panelists may also explore current trending areas of interest, and what they see as emerging fields in the near future.

By Joey Wong, Investor Research Analyst, Hong Kong BD, LSN

Partnering events can be the best ways to engage with potential investors and strategic partners in the early-stage arena. Life Science Nation is offering a series of free webinars to help life science and healthcare entrepreneurs make the most out of partnering events, such as Digital RESI, November 15-16, 2022 and RESI San Francisco, January 10-12, 2023. These webinars offer tactical advice to early-stage companies on how to maximize outcomes when attending conferences like RESI and moving connections beyond the event. Attend these complimentary webinars and save $1,000 on a special bundle deal for Digital RESI November and RESI San Francisco by October 21.

Register below to join these complimentary online sessions:

October 20, 1:30 PM EDT – Sign-up

The Best Partnering Practice: Virtually vs. Face-to-Face

Greg Mannix, Vice President, International Business Development, General Manager, Europe, Life Science Nation

Partnering in the digital world of the past few years has taught us all new skills. Now that in-person events have returned—often with a “hybrid” component—there are some key tactics you should keep in mind to get the best results.

---

November 1, 1:00 PM EDT – Sign-up

Partnering Live Tutorial

Antoinette Lowre, Manager, Business Development, Life Science Nation

This partnering tutorial covers basic functions of the RESI partnering platform, how to set up your profile, how to search for investors/strategic partners, how to book and request meetings and what your outreach strategy should look like when requesting meetings.

---

November 2, 12:00 PM EDT – Sign-up

Pitching at the Biggest Partnering Event of the Year (Session 1)

Karen Deyo, Director, Investor Research, Israel Business Development, Life Science Nation

Alexander Vassallo, Manager, Business Development, Life Science Nation

As RESI returns to JPM week next January, the biggest partnering event of the year for the life sciences industry, so does the Innovator’s Pitch Challenge (IPC). Being able to deliver a powerful and compelling pitch to portray why your company’s unique technology should be an investor’s top interest can help make this week potentially one of the most productive of the year. Join Karen and Alex on this webinar to discuss making the most of your pitch opportunity at JPM week next year!

---

November 22, 11:00 AM EDT – Sign-up

Pitching at the Biggest Partnering Event of the Year (Session 2)

Candice He, Vice President, Business Development, Global Investment Strategist, Life Science Nation

Claire Jeong, Chief Conference Officer, Vice President, Investor Research, Asia Business Development, Life Science Nation

As RESI returns to JPM week next January, the biggest partnering event of the year for the life sciences industry, so does the Innovator’s Pitch Challenge (IPC). Being able to deliver a powerful and compelling pitch to portray why your company’s unique technology should be an investor’s top interest can help make this week potentially one of the most productive of the year. Join Karen and Alex on this webinar to discuss making the most of your pitch opportunity at JPM week next year!

By Antoinette Lowre, Manager of Business Development, LSN

Life Science Nation (LSN)’s RESI conference series is one of the only early-stage focused partnering experiences in the life science and healthcare ecosystem. All players use RESI to rally their partnership and fundraising goals. Sponsoring RESI is the fast-track to reaching these goals.

Benefits of sponsoring a RESI conference include increasing global brand and reach, sourcing, vetting and developing key relationships with your target audience, showcase your product and services through workshops and panels, and use our one-of-a-kind match-based partnering platform to connect with strategic partners and build relationships.

Check out our Sponsorship Brochure to meet your goals and reach your intended audience. Contact your BD rep to learn more on how to sponsor and gain visibility at Digital RESI, November 15-16, 2022 and RESI San Francisco, January 10-12, 2023

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

If the pandemic taught us anything, it is that there is more than one way to skin a cat. Making connections and doing business while being hundreds or thousands of miles apart from our counterparts seemed like a ridiculous proposition only a few years ago, but alas! Nobody thinks that way today.

In fact, the RESI conference successfully created a digital platform for exactly that: making connections and doing business. Early-stage companies, investors, strategics and service providers discovered how to make the best of the situation and be very productive. The usefulness of remote, virtual meetings is evident today and will likely be around for the foreseeable future. But we saw last month at RESI Boston that there is a real desire to return to face-to-face gatherings.

While virtual meetings will continue to be useful, the return to in-person partnering conferences like RESI Boston and the upcoming RESI San Francisco, January10-12 have important advantages:

• Ad-hoc meetings throughout the day
• Networking receptions
• The undeniable power of a handshake (or elbow bump!)

To that end, any company in the early-stage life sciences arena must have JPM week in January in San Francisco on their radar. It’s the week that thousands of relevant investors, strategic partners and new technology startups converge on the City by the Bay to look for opportunities to connect and do business. Apart from scheduling planned meetings throughout the week, every evening is full of networking events to make more connections. It can be the most productive week of the year for many companies!

RESI San Francisco,, January 10-12, 2023 is a key part of JPM week. For early-stage players, it is, without a doubt, the best venue to identify and meet 500+ global investors and strategic partners. The RESI Partnering Platform allows you to schedule multiple meetings with the right counterparts on January 10. For the following two days, you can schedule both virtual and in-person meetings anywhere in the city using the RESI Partnering Platform.

As a lead-up to JPM week, LSN is offering a Digital RESI, November 15-16 partnering event. You can meet virtually with 200+ investors and strategics to get the most out of the final quarter of 2022 and be ready for new and follow-up meetings in January. We are offering a super discount bundle package for RESI November & RESI JPM San Francisco.

Bundle Package Earlybird Offer – Digital RESI November + RESI JPM San Francisco